Den hyppigst rapporterede behandlingsrelaterede, uønskede virkning med TRAVATAN - monoterapi var hyperæmi i øjet (22, 3%), der omfattede okulær, konjunktival eller skleral hyperæmi.
The most frequently reported treatment-related undesirable effect with TRAVATAN monotherapy was hyperaemia of the eye (22.3%), which included ocular, conjunctival, or scleral hyperaemia.